Undetected Multidrug-Resistant Tuberculosis Amplified by First-line Therapy in Mixed Infection
Infections with >1 Mycobacterium tuberculosis strain(s) are underrecognized. We show, in vitro and in vivo, how first-line treatment conferred a competitive growth advantage to amplify a multidrug-resistant M. tuberculosis strain in a patient with mixed infection. Diagnostic techniques that ident...
Main Authors: | Suzanne M. Hingley-Wilson, Rosalyn Casey, David Connell, Samuel Bremang, Jason T. Evans, Peter M. Hawkey, Grace E. Smith, Annette Jepson, Stuart Philip, Onn Min Kon, Ajit Lalvani |
---|---|
Format: | Article |
Language: | English |
Published: |
Centers for Disease Control and Prevention
2013-07-01
|
Series: | Emerging Infectious Diseases |
Subjects: | |
Online Access: | https://wwwnc.cdc.gov/eid/article/19/7/13-0313_article |
Similar Items
-
Distinguishing Nontuberculous Mycobacteria from Multidrug-Resistant Mycobacterium tuberculosis, China
by: Kaijin Xu, et al.
Published: (2014-06-01) -
Multidrug-Resistant Tuberculosis, People’s Republic of China, 2007–2009
by: Guang Xue He, et al.
Published: (2011-10-01) -
Acquired Drug Resistance in Mycobacterium tuberculosis and Poor Outcomes among Patients with Multidrug-Resistant Tuberculosis
by: Russell R. Kempker, et al.
Published: (2015-06-01) -
Use of Spatial Information to Predict Multidrug Resistance in Tuberculosis Patients, Peru
by: Hsien-Ho Lin, et al.
Published: (2012-05-01) -
Concomitant Multidrug-resistant Pulmonary Tuberculosis and Susceptible Tuberculous Meningitis
by: Christine Bernard, et al.
Published: (2014-03-01)